Results 91 to 100 of about 5,904 (237)

Intraurethral alprostadil for the treatment of erectile dysfunction [PDF]

open access: yesClinical Practice, 2014
Erectile dysfunction (ED) is a significant and common health disorder affecting males and, indirectly, their partners and families. Largely due to the increased aging population, the incidence of ED is steadily increasing. While ED is not life threatening, it is associated with increased morbidity, representing a disorder that affects an individual’s ...
openaire   +1 more source

Effects of injection Shenkang and alprostadil combination on contrast-induced nephropathy in patient with diabetes complicated with mild to moderate renal insufficiency

open access: yesBangladesh Journal of Pharmacology, 2017
The diabetic patients (n=109) with mild or moderate renal insufficiency underwent coronary intervention were randomly divided into control group and observation group. The patients in observation group were treated with injection Shenkang and alprostadil
Yanfang Zhang   +3 more
doaj   +1 more source

Identification of Drugs that Regulate Dermal Stem Cells and Enhance Skin Repair

open access: yesStem Cell Reports, 2016
Here, we asked whether we could identify pharmacological agents that enhance endogenous stem cell function to promote skin repair, focusing on skin-derived precursors (SKPs), a dermal precursor cell population.
Sibel Naska   +9 more
doaj   +1 more source

Impact of anticoagulation and vasoactive medication on regained radial artery patency after catheterization: a case–control study

open access: yesEuropean Journal of Medical Research, 2018
Background Radial artery access is the primary approach for coronary interventions due to higher safety profile in comparison to femoral access. Radial artery occlusion (RAO) is the main complication of transradial catheterization that can lead to severe
C. Rammos   +6 more
doaj   +1 more source

Acute macular edema following intracorporeal prostaglandin injection for erectile dysfunction

open access: yesInternational Medical Case Reports Journal, 2015
Masumi G Asahi, Calvin Chou, Ron P Gallemore Retina Macula Institute, Torrance, CA, USA Purpose: We aimed to describe the first case of macular edema following intracorporeal injection of alprostadil, a prostaglandin E1.
Asahi MG, Chou C, Gallemore RP
doaj  

APPLICATION EXPERIENCE OF ALPROSTADIL FOR THE PATIENT, SUFFERING FROM SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTI-PHOSPHOLIPID SYNDROME

open access: yesПедиатрическая фармакология, 2006
The article deals with the clinical case of alprostadil application for the patient, suffering from systemic lupus erythematosus (SLE) and severe anti-phospholipid syndrome, which was complicated by the arterial thrombosis.
E.I. Alexeeva   +3 more
doaj   +2 more sources

Intra-Arterial Prostaglandin E1 Infusion in Patients with Rest Pain: Short-Term Results

open access: yesThe Scientific World Journal, 2012
Purpose. To present our results after short-term (1 month) intra-arterial infusion therapy of PGE1-alprostadil via a port system implanted in the ipsilateral external iliac artery (EIA) in patients with severe rest pain. Methods. Ten patients with severe
A. Chatziioannou   +4 more
doaj   +1 more source

Effect of alprostadil on erythrocyte deformability in ischemia reperfusion injury

open access: yesBratislava Medical Journal, 2015
Ischemia reperfusion injury (I/R) in lower extremity is a frequent and important clinical phenomenon. Protective effect of alprostadil on local and distant organ injury due to I/R has been well-documented but its effect on erythrocyte deformability needs further investigation.
Kara, HALİL   +8 more
openaire   +7 more sources

Home - About - Disclaimer - Privacy